Journal
Cancer Discovery
Publication Date
11-2-2022
Volume
12
Issue
11
First Page
2586
Last Page
2605
Document Type
Open Access Publication
DOI
10.1158/2159-8290.CD-22-0200
Rights and Permissions
Anurag M, Jaehnig EJ, Krug K, Lei JT, Bergstrom EJ, Kim BJ, Vashist TD, Huynh AMT, Dou Y, Gou X, Huang C, Shi Z, Wen B, Korchina V, Gibbs RA, Muzny DM, Doddapaneni H, Dobrolecki LE, Rodriguez H, Robles AI, Hiltke T, Lewis MT, Nangia JR, Nemati Shafaee M, Li S, Hagemann IS, Hoog J, Lim B, Osborne CK, Mani DR, Gillette MA, Zhang B, Echeverria GV, Miles G, Rimawi MF, Carr SA, Ademuyiwa FO, Satpathy S, Ellis MJ. Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. Cancer Discov. 2022 Nov 2;12(11):2586-2605. doi: 10.1158/2159-8290 This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license
Recommended Citation
Anurag, Meenakshi; Li, Shunqiang; Hagemann, Ian S; Hoog, Jeremy; Ademuyiwa, Foluso O; and et al., "Proteogenomic markers of chemotherapy resistance and response in triple-negative breast cancer." Cancer Discovery. 12, 11. 2586 - 2605. (2022).
https://digitalcommons.wustl.edu/oa_4/933
Additional Links
Supplemental material is available for this article at publisher site.
